Literature DB >> 33954904

Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair.

Tatjana Marinkovic1, Dragan Marinkovic2.   

Abstract

MYC is well known as a potent oncogene involved in regulating cell cycle and metabolism. Augmented MYC expression leads to cell cycle dysregulation, intense cell proliferation, and carcinogenesis. Surprisingly, its increased expression in neurons does not induce their proliferation, but leads to neuronal cell death and consequent development of a neurodegenerative phenotype. Interestingly, while cancer and neurodegenerative diseases such as Alzheimer's disease are placed at the opposite sides of cell division spectrum, both start with cell cycle dysregulation and stimulation of proliferation. It seems that MYC action directed toward neuron cell proliferation and neural tissue repair collides with evolutional loss of regenerative capacity of CNS neurons in order to strengthen synaptic structure, to protect our cognitive abilities and therefore character. Accordingly, there are abundant mechanisms that block its expression and action specifically in the brain. Moreover, while MYC expression in brain neurons during neurodegenerative processes is related to their death, there are obvious evidences that MYC action after physical injury is beneficial in case of peripheral nerve recovery. MYC might be a useful tool to repair brain cells upon development of neurodegenerative disease or CNS trauma, including stroke and traumatic brain and spinal cord injury, as even imperfect axonal growth and regeneration strategies will likely be of profound benefit. Understanding complex control of MYC action in the brain might have important therapeutic significance, but also it may contribute to the comprehension of development of neurodegenerative diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Brain; MYC; Neurodegenerative diseases; Neuronal degeneration; Neuronal repair

Mesh:

Substances:

Year:  2021        PMID: 33954904     DOI: 10.1007/s12035-021-02406-w

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  74 in total

1.  Metabolic control of the cell cycle.

Authors:  Joanna Kalucka; Rindert Missiaen; Maria Georgiadou; Sandra Schoors; Christian Lange; Katrien De Bock; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Tissue repair: The hidden drama.

Authors:  Kristine P Krafts
Journal:  Organogenesis       Date:  2010 Oct-Dec       Impact factor: 2.500

Review 3.  The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.

Authors:  Olga Lancho; Daniel Herranz
Journal:  Trends Cancer       Date:  2018-11-02

Review 4.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

Review 5.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

6.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

Review 7.  Metabolism and proliferation share common regulatory pathways in cancer cells.

Authors:  V Fritz; L Fajas
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

9.  Reversible lymphomagenesis in conditionally c-MYC expressing mice.

Authors:  Dragan Marinkovic; Tatjana Marinkovic; Bettina Mahr; Jochen Hess; Thomas Wirth
Journal:  Int J Cancer       Date:  2004-06-20       Impact factor: 7.396

Review 10.  c-MYC: more than just a matter of life and death.

Authors:  Stella Pelengaris; Mike Khan; Gerard Evan
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

View more
  3 in total

1.  Gene expression data analysis using Hellinger correlation in weighted gene co-expression networks (WGCNA).

Authors:  Tianjiao Zhang; Garry Wong
Journal:  Comput Struct Biotechnol J       Date:  2022-07-13       Impact factor: 6.155

2.  Synergistic effects of epigallocatechin gallate and l-theanine in nerve repair and regeneration by anti-amyloid damage, promoting metabolism, and nourishing nerve cells.

Authors:  Xinya Xie; Juan Wan; Xin Zheng; Wenjing Pan; Jiayi Yuan; Baozhu Hu; Meiyan Feng; Zhonghua Liu; Shuxian Cai
Journal:  Front Nutr       Date:  2022-08-10

Review 3.  Oncogenic Pathways in Neurodegenerative Diseases.

Authors:  Luis Varela; Maria E R Garcia-Rendueles
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.